133 related articles for article (PubMed ID: 9750810)
1. [Prolonged neuromuscular blockade with mivacurium in a newborn].
Doucet O; Martin L; Laffon M; Jonville-Bera AP; Mercier C
Ann Fr Anesth Reanim; 1998; 17(7):725-7. PubMed ID: 9750810
[TBL] [Abstract][Full Text] [Related]
2. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia.
Frampton JE; McTavish D
Drugs; 1993 Jun; 45(6):1066-1089. PubMed ID: 7691494
[TBL] [Abstract][Full Text] [Related]
3. Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury.
Martyn JA; Goudsouzian NG; Chang Y; Szyfelbein SK; Schwartz AE; Patel SS
Anesthesiology; 2000 Jan; 92(1):31-7. PubMed ID: 10638896
[TBL] [Abstract][Full Text] [Related]
4. Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase.
Ostergaard D; Jensen FS; Jensen E; Skovgaard LT; Viby-Mogensen J
Acta Anaesthesiol Scand; 1993 Apr; 37(3):314-8. PubMed ID: 8390770
[TBL] [Abstract][Full Text] [Related]
5. [The clinical pharmacology of mivacurium].
Diefenbach C; Mellinghoff H
Anaesthesist; 1997 May; 46(5):385-8. PubMed ID: 9245207
[TBL] [Abstract][Full Text] [Related]
6. [Neuromuscular recovery following mivacurium is predictable in patients with severe systemic disease prognoses].
Blobner M; Busley R; Mann R; Jelen-Esselborn S; Kochs E
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Oct; 34(10):638-41. PubMed ID: 10548961
[TBL] [Abstract][Full Text] [Related]
7. Prolonged paralysis after a test dose of mivacurium in a patient with atypical serum cholinesterase.
Vanlinthout LE; Bartels CF; Lockridge O; Callens K; Booij LH
Anesth Analg; 1998 Nov; 87(5):1199-202. PubMed ID: 9806709
[No Abstract] [Full Text] [Related]
8. Screening patients with prolonged neuromuscular blockade after succinylcholine and mivacurium.
Cerf C; Mesguish M; Gabriel I; Amselem S; Duvaldestin P
Anesth Analg; 2002 Feb; 94(2):461-6, table of contents. PubMed ID: 11812719
[TBL] [Abstract][Full Text] [Related]
9. Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients.
Ostergaard D; Jensen FS; Jensen E; Skovgaard LT; Viby-Mogensen J
Acta Anaesthesiol Scand; 1992 Oct; 36(7):702-6. PubMed ID: 1441874
[TBL] [Abstract][Full Text] [Related]
10. Prolonged mivacurium neuromuscular block in children.
Lejus C; Blanloeil Y; Le Roux N; Soulard D; Mesguish M; Burnat P; Duvaldestin P; Pinaud M
Paediatr Anaesth; 1998; 8(5):433-5. PubMed ID: 9742542
[TBL] [Abstract][Full Text] [Related]
11. The clinical and basic pharmacology of mivacurium: a short-acting nondepolarizing benzylisoquinolinium diester neuromuscular blocking drug.
Savarese JJ; Lien CA; Belmont MR; Rubin L
Acta Anaesthesiol Scand Suppl; 1995; 106():18-22. PubMed ID: 8533538
[TBL] [Abstract][Full Text] [Related]
12. Prolonged neuromuscular block associated with mivacurium.
Fox MH; Hunt PC
Br J Anaesth; 1995 Feb; 74(2):237-8. PubMed ID: 7696077
[TBL] [Abstract][Full Text] [Related]
13. [Plasma cholinesterase variations as a result of prolonged neuromuscular blockade. Review and problems encountered in two cases of prolonged neuromuscular blockade after muscle relaxation with succinylcholine as compared to mivacurium].
Lang C; Lukasewitz P; Wulf H; Geldner G
Anaesthesist; 2002 Feb; 51(2):134-41. PubMed ID: 11963306
[TBL] [Abstract][Full Text] [Related]
14. Mivacurium and prolonged neuromuscular block.
Davis L
Br J Anaesth; 1995 Sep; 75(3):374. PubMed ID: 7547070
[No Abstract] [Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA).
Østergaard D; Viby-Mogensen J; Rasmussen SN; Gätke MR; Pedersen NA; Skovgaard LT
Acta Anaesthesiol Scand; 2003 Nov; 47(10):1219-25. PubMed ID: 14616318
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase.
Naguib M; Daoud W; el-Gammal M; Ammar A; Turkistani A; Selim M; Altamimi W; Sohaibani MO
Anesthesiology; 1995 Oct; 83(4):694-701. PubMed ID: 7574048
[TBL] [Abstract][Full Text] [Related]
17. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.
Savarese JJ; Ali HH; Basta SJ; Embree PB; Scott RP; Sunder N; Weakly JN; Wastila WB; el-Sayad HA
Anesthesiology; 1988 May; 68(5):723-32. PubMed ID: 2967039
[TBL] [Abstract][Full Text] [Related]
18. [Value of the monitoring of curarisation during prolonged mivacurium induced neuromuscular block].
Avargues P; Cros AM; Dardel E; Darriet M; Biteau N
Ann Fr Anesth Reanim; 1995; 14(6):511-3. PubMed ID: 8745977
[TBL] [Abstract][Full Text] [Related]
19. Is the recovery profile of mivacurium independent of the rate of decay of its plasma concentration in patients with normal plasma cholinesterase activity?
Nijs N; Duvaldestin P; Slavov V; Dhonneur G
Acta Anaesthesiol Scand; 1998 Nov; 42(10):1175-9. PubMed ID: 9834800
[TBL] [Abstract][Full Text] [Related]
20. Changes in plasma cholinesterase activity and mivacurium neuromuscular block in response to normothermic cardiopulmonary bypass.
Diefenbach C; Abel M; Rump AF; Grond S; Korb H; Buzello W
Anesth Analg; 1995 Jun; 80(6):1088-91. PubMed ID: 7762834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
